Filing Details

Accession Number:
0001033905-13-000157
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-18 10:41:42
Reporting Period:
2013-09-16
Filing Date:
2013-09-18
Accepted Time:
2013-09-18 10:41:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1033905 Luminex Corp LMNX Surgical & Medical Instruments & Apparatus (3841) 742747608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238407 T Harriss Currie 12212 Technology Boulevard
Austin TX 78727
Vp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-16 20,000 $8.41 187,748 No 4 M Direct
Common Stock Disposition 2013-09-16 20,000 $20.00 167,748 No 4 S Direct
Common Stock Acquisiton 2013-09-17 10,000 $8.41 177,748 No 4 M Direct
Common Stock Disposition 2013-09-17 10,000 $19.61 167,748 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2013-09-16 20,000 $0.00 20,000 $8.41
Common Stock Stock Option (Right To Buy) Disposition 2013-09-17 10,000 $0.00 10,000 $8.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,000 2007-10-13 2013-10-13 No 4 M Direct
55,000 2007-10-13 2013-10-13 No 4 M Direct
Footnotes
  1. The option exercises and stock sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2012.
  2. Includes 206 shares acquired under the Luminex Corporation Employee Stock Purchase Plan on June 28, 2013.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.26 inclusive. Mr. Currie undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $19.66 inclusive. Mr. Currie undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
  5. The option vested in 48 equal monthly installments beginning November 13, 2003.